Tissue Engineering Innovations
Solutions To Global Problems
Macular degeneration is a leading cause of vision loss in Americans 60 years of age and older. As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
Estimates of the global cost of visual impairment due to age-related macular degeneration is $343 billion, including $255 billion in direct health care costs.
The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
The number of Americans that have kidney failure. Of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant.
The estimated global cost of visual impairment due to age-related macular degeneration is $343 billion, including $255 billion in direct health care costs.
Macular Degeneration Crisis
Current treatments cannot cure macular degeneration. Surgery, Eye Injections, Eye Supplements and Gene Therapy can slow the progression, and are often expensive. Gene therapy for example costs $850,000 for both eyes to be treated.
Mesogen Will Solve This Crisis
Twelve People Die Everyday Waiting for a Kidney Transplant.
Mesogen is developing custom human kidneys from the patient’s own stem cells to replace failing kidneys. These kidneys can be grown in about 12 months with our proprietary process.
The patient will not require long term anti-rejection drugs and will have a better quality of life with less complications.
Mesogen will be a provider of autologous engineered Retinal Pigment Epithelium (RPE) cell patches for transplant. This will be a curative treatment. Headquartered in the Woodlands, Texas, in the United States, the company will focus on solving some of the largest problems facing humanity through advanced tissue engineering innovations.
A Cure Is Coming
Take The First Step Towards Your Future
Take control of your future and contact us today. Mesogen is actively seeking investors, physicians and patients at various stages of development. Reach out today, and let us discuss how Mesogen can help you with your future.